Supplemental Table 1.
Variable | Combined primary maternal endpoint |
||
---|---|---|---|
n (column %) | Crude or only BMI (aOR [95% CI])a | Multivariable (aOR [95% CI])b | |
Model 1 | |||
GDM | |||
No GDM or preexisting DM | 1335 (90.6) | Ref | Ref |
GDM, no DM | 138 (9.4) | 1.56 (0.94–2.59) | 1.50 (0.87–2.56) |
BMIc | |||
Underweight or normal weight (<25 kg/m2) | 796 (54.0) | Ref | Ref |
Overweight (≥25 kg/m2) | 380 (25.8) | 2.28 (1.50–3.46)d | 1.84 (1.19–2.85)d |
Obese (≥30 kg/m2) | 297 (20.2) | 2.32 (1.48–3.64)d | 1.90 (1.17–3.07)d |
Model 2 | |||
No GDM or DM, underweight or normal weight | 761 (51.7) | Ref | Ref |
No GDM or DM, overweight | 335 (22.7) | 2.34 (1.5–3.64)d | 1.87 (1.18–2.97)d |
No GDM or DM, obese | 239 (16.2) | 2.43 (1.5–3.94)d | 2.01 (1.21–3.37)d |
GDM, underweight or normal weight | 35 (2.4) | 2.10 (0.71–6.22) | 2.01 (0.65–6.25) |
GDM, overweight | 45 (3.1) | 3.52 (1.55–8.02)d | 2.90 (1.21–6.95)d |
GDM, obese | 58 (3.9) | 3.40 (1.61–7.16)d | 2.54 (1.13–5.67)d |
Data are presented as aOR (CI) using logistic regression analyses with combined primary maternal endpoint (yes or no) as the dependent variable.
aOR, odds ratio; BMI, body mass index; CI, confidence interval; DM, diabetes mellitus; GDM, gestational diabetes mellitus; Ref, reference interval.
Kleinwechter. Gestational diabetes mellitus and COVID-19: COVID-19–Related Obstetric and Neonatal Outcome Study registry results. Am J Obstet Gynecol 2022.
Model 1 adjusted for BMI only and model 2 unadjusted
Additionally adjusted for week of gestation at the onset of COVID-19 symptoms (or at a positive polymerase chain reaction test result), multiples (yes or no), maternal age at positive COVID-19 test result, language competence (communication possible with or without problems), nicotine or smoking during pregnancy (yes or no), parity (0 or ≥1), and hypertensive disorders in pregnancy (yes or no)
Maternal BMI before or at the beginning of pregnancy (kg/m2)
P<.05.